Amycretin mastery course
Unit 10 of 12

Dosing & Administration

This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published…

The trial schedules, and why you cannot buy it

This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published research. It is not a protocol or a recommendation. Amycretin is not approved in the United States, and the only supply any source in this course describes is Novo Nordisk's own clinical trials.

The honest throughline: the only real dosing information comes from the trials, both formulations climb the dose slowly, and anything sold online as "research peptide" amycretin is unverified, with no compounding route shown to reach it.

Key terms

The trial-validated schedules

The only legitimate dosing information for amycretin comes from its trials, and it is presented here as research context, not a prescription. The two formulations differ: the oral tablet is once daily, the subcutaneous injection is once weekly, and both climb the dose in steps over weeks.

The two trial regimens (reference only)
What the trial regimens define

Two points matter most. First, the optimal maintenance dose is not yet established, because these were dose-finding trials, not confirmatory ones. Second, these figures describe a product given to participants inside a trial, not a number anyone should act on with an online vial.

Important

This unit is education only and not medical advice. The trial regimens are research reference information, not a recommendation to use amycretin.


Why the climb is slow


Why you cannot legally get it


Reading dosing claims critically


Common dosing myths, checked


What the trials actually reported